Imipenem

Common Uses

Imipenem is used to treat severe infections caused by bacteria in many different parts of the body. It is often prescribed for patients in a hospital setting who have complex or multi-drug resistant infections. Common indications include:

• Lower respiratory tract infections: Including severe cases of pneumonia.
• Urinary tract infections: Both complicated and uncomplicated infections of the bladder or kidneys.
• Intra-abdominal infections: Infections occurring within the stomach or abdominal cavity.
• Gynecological infections: Serious infections of the female reproductive system.
• Skin and soft tissue infections: Severe infections of the skin and underlying structures.
• Bone and joint infections: Bacterial infections affecting the skeletal system.
• Bacterial endocarditis: An infection of the heart's inner lining or valves.
• Septicemia: Serious infections that have spread into the bloodstream.

This medication is only effective against bacterial infections and will not work for viral infections such as the common cold or flu.

Mechanism of Action

Imipenem belongs to a class of medications called carbapenem antibiotics. It works by interfering with the production of the bacterial cell wall. The cell wall is essential for the survival of bacteria; when imipenem disrupts its formation, the bacteria lose their structural integrity and eventually rupture and die.

Role of Cilastatin

Imipenem is almost always administered in combination with cilastatin. While imipenem is the component that kills bacteria, cilastatin serves a protective role. It works by:

• Inhibiting a specific enzyme in the kidneys that breaks down imipenem.
• Allowing the antibiotic to stay active in the body for a longer period.
• Helping the medication reach higher concentrations in the urine to treat certain types of infections.

This combination allows the antibiotic to be more effective against a wide range of serious infections caused by various types of bacteria. It is important to note that this medication only treats bacterial infections and is not effective against viruses, such as those that cause the flu or the common cold.

Common Side Effects

Many people using imipenem do not experience significant side effects. When they do occur, common symptoms may include:

• Nausea or vomiting
• Diarrhea
• Dizziness or sleepiness
• Pain, redness, or swelling at the site where the medication was injected

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious side effects:

• Seizures, especially in individuals with a history of brain disorders or kidney disease
• Signs of an allergic reaction, such as hives, skin rash, itching, or swelling of the face, lips, or throat
• Difficulty breathing or swallowing
• Severe stomach cramps and watery or bloody diarrhea, which may occur during treatment or several months after stopping
• Confusion, tremors, or muscle twitching
• Unusual bruising or bleeding

Allergic Reactions

Serious and occasionally fatal hypersensitivity (allergic) reactions have been reported. These reactions are more likely to occur in individuals with a history of sensitivity to multiple allergens. There is a risk of cross-reactivity, meaning people allergic to penicillins, cephalosporins, or other beta-lactam antibiotics may also react to imipenem.

Central Nervous System Effects

Imipenem has been associated with central nervous system side effects, including:

• Seizures: These are most common in patients with existing central nervous system disorders, such as brain lesions or a history of seizures, and those with impaired kidney function.
• Confusional states: Some patients may experience confusion, dizziness, or tremors.

If focal tremors or seizures occur during treatment, a neurological evaluation is typically recommended, and the dosage may need to be adjusted or the medication discontinued.

Kidney Impairment

Because the medication is primarily cleared through the kidneys, individuals with decreased kidney function are at a higher risk of experiencing adverse effects, particularly seizures. Healthcare providers usually monitor kidney function and adjust the dose accordingly to prevent the drug from reaching toxic levels in the body.

Severe Diarrhea

Like many antibiotics, imipenem can cause Clostridioides difficile-associated diarrhea (CDAD). This condition occurs when the normal bacteria in the colon are altered, allowing the C. diff bacteria to grow. It can range in severity from mild diarrhea to fatal colitis. This may occur during treatment or several months after the medication is stopped.

Other Considerations

Prolonged use of imipenem may result in the overgrowth of non-susceptible organisms, such as fungi. If a secondary infection occurs, appropriate therapy must be started. Additionally, the safety and effectiveness of certain administration routes (such as intramuscular) have not been established for children with severe infections or those with kidney impairment.

Pregnancy

There are no adequate and well-controlled studies of imipenem in pregnant women. Animal studies have shown some adverse effects on the fetus at high doses. Because of this, healthcare providers generally only prescribe this medication during pregnancy if the potential benefit justifies the potential risk to the developing baby.

Breastfeeding

It is currently unknown whether imipenem passes into human breast milk. Because many medications can be excreted in milk and may affect a nursing infant, it is important to discuss the risks and benefits with a healthcare provider before breastfeeding while using this medication.

Available Forms

Imipenem is supplied as a powder that must be mixed with a liquid before use. It is available in the following administration forms:

• Intravenous Infusion: The medication is dissolved and delivered through a needle or catheter into a vein.
• Intramuscular Injection: The medication is prepared for delivery via an injection into a large muscle.

Imipenem is commonly combined with cilastatin to ensure the antibiotic remains active in the body for a longer period. It is not available in oral forms such as tablets or capsules.

FDA Approval and Indications

Imipenem is approved by the U.S. Food and Drug Administration (FDA) for the treatment of serious infections caused by susceptible strains of microorganisms. It is most commonly used in a fixed-dose combination with cilastatin, which prevents the breakdown of imipenem in the kidneys.

Approved indications for the imipenem and cilastatin combination include:

• Lower respiratory tract infections
• Urinary tract infections
• Intra-abdominal infections
• Gynecologic infections
• Bacterial septicemia
• Bone and joint infections
• Skin and skin structure infections
• Endocarditis

Regulatory Considerations

While imipenem is effective against a wide range of bacteria, its use is generally reserved for serious infections to help prevent the development of drug-resistant bacteria. There are currently no boxed warnings or Risk Evaluation and Mitigation Strategies (REMS) associated with this medication in the provided regulatory documentation. However, healthcare providers are advised to monitor for potential central nervous system effects, such as seizures, particularly in patients with underlying renal impairment or CNS disorders.

FDA-Approved Indications

Imipenem is approved by the U.S. Food and Drug Administration (FDA) for use in combination with cilastatin. This combination is indicated for the treatment of serious infections caused by susceptible bacteria in the following areas:

• Lower respiratory tract infections
• Urinary tract infections (both complicated and uncomplicated)
• Intra-abdominal infections
• Gynecologic infections
• Bacterial septicemia (bloodstream infections)
• Bone and joint infections
• Skin and skin structure infections
• Endocarditis (infection of the heart lining or valves)

FDA Safety and Usage Information

The FDA has approved this medication for administration via intravenous infusion or intramuscular injection. It is not available in an oral form because it is not effectively absorbed by the stomach.

FDA-mandated labeling includes specific warnings regarding the risk of central nervous system (CNS) adverse reactions. These may include tremors or seizures, particularly in patients with pre-existing CNS disorders or those with impaired kidney function. The FDA also highlights the risk of severe hypersensitivity (allergic) reactions, especially in individuals with a known sensitivity to multiple allergens or other beta-lactam antibiotics like penicillin.